Clinical Trial Update: Pharmacodynamic Study of BKM120 in Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports on the pharmacodynamic study of BKM120 (buparlisib) in breast cancer in an early-phase trial. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BKM120 (Buparlisib)

Snippet

Sponsor: Sofia Perea, Director Clinical Trials Unit. | Conditions: Breast Cancer | EARLY_Phase 1 | Status: COMPLETED